| MeSH term | MeSH ID | Detail |
|---|---|---|
| Osteoarthritis, Knee | D020370 | 13 associated lipids |
| Prosthesis-Related Infections | D016459 | 7 associated lipids |
| Fractures, Stress | D015775 | 2 associated lipids |
| Osteoporosis, Postmenopausal | D015663 | 4 associated lipids |
| Thyroid Diseases | D013959 | 8 associated lipids |
| Carcinoma, Ductal, Breast | D018270 | 19 associated lipids |
| Myocardial Ischemia | D017202 | 11 associated lipids |
| Paraneoplastic Syndromes | D010257 | 4 associated lipids |
| Sepsis | D018805 | 11 associated lipids |
| Periodontal Pocket | D010514 | 9 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Whitney MJ et al. | Leukemia inhibitory factor secretion is a predictor and indicator of early progenitor status in adult bone marrow stromal cells. | 2009 | Tissue Eng Part A | pmid:18637760 |
| Hasegawa T et al. | Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro. | 2002 | Tissue Cell | pmid:11989970 |
| Carda C et al. | Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint. | 2005 | Tissue Cell | pmid:15899507 |
| Mikosch P et al. | High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy. | 2008 | Thyroid | pmid:18302515 |
| Martini G et al. | The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. | 2008 | Thyroid | pmid:18399769 |
| Vinholt PJ et al. | An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. | 2013 | Thromb. Res. | pmid:23531238 |
| Guldiken B et al. | Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct. | 2007 | Thromb. Res. | pmid:17258300 |
| Hyseni A et al. | Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. | 2013 | Thromb. Res. | pmid:23273402 |
| Vik A et al. | Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. | 2012 | Thromb. Res. | pmid:22909822 |
| O'Sullivan EP et al. | Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. | 2010 | Thromb. Res. | pmid:20932553 |
| Al-Fakhri N et al. | Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification. | 2005 | Thromb. Haemost. | pmid:16411417 |
| Vik A et al. | Heparin induces mobilization of osteoprotegerin into the circulation. | 2007 | Thromb. Haemost. | pmid:17598007 |
| Vik A et al. | Serum osteoprotegerin in young survivors of myocardial infarction. | 2006 | Thromb. Haemost. | pmid:16676081 |
| Hofbauer LC et al. | Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cells. | 2006 | Thromb. Haemost. | pmid:16601843 |
| Kees M et al. | Elevated plasma osteoprotegerin levels are associated with venous thrombosis and bleeding in patients with polycythemia vera. | 2005 | Thromb. Haemost. | pmid:15630493 |
| Celińska-Löwenhoff M et al. | Effects of hypolipemic drugs on the osteoprotegerin - sRANKL system in patients with coronary artery disease. | 2007 | Thromb. Haemost. | pmid:17479201 |
| Brandenburg V et al. | Calcification inhibitors in vascular calciphylaxis associated with normal renal function. | 2012 | Thromb. Haemost. | pmid:23092963 |
| Hess U | [The plasma cell myeloma--molecular pathogenesis and target therapies]. | 2006 | Ther Umsch | pmid:16689452 |
| Yokoyama K et al. | Low blood osteoprotegerin levels are a predictor to poor prognosis in Japanese patients on hemodialysis due to diabetic nephropathy. | 2008 | Ther Apher Dial | pmid:18503706 |
| Chasseraud M et al. | Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. | 2011 | Ther Apher Dial | pmid:21426505 |